
SAB Biotherapeutics Deck
SAB Biotherapeutics (SAB) is a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces targeted, high potency, fully-human polyclonal antibodies at scale.
This post is for subscribers only
SubscribeAlready have an account? Log in